Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis

<p>Abstract</p> <p>Corticosteroids are standard treatment for patients with multiple sclerosis experiencing acute relapse. Because dyspeptic pain is a common side effect of this intervention, patients can be given a histamine receptor-2 antagonist, proton pump inhibitor or antacid...

Full description

Bibliographic Details
Main Authors:	Biswas Sangita, Benedict Stephen H, Lynch Sharon G, LeVine Steven M
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Series:	BMC Medicine
Subjects:	Antacid autoimmune dyspepsia experimental autoimmune encephalomyelitis GERD histamine receptor 2 antagonists multiple sclerosis proton pump inhibitor
Online Access:	http://www.biomedcentral.com/1741-7015/10/57

Similar Items

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Acid-neutralising capacity and pharmacoeconomic studies of commercially available antacids in the Qassim Region of Saudi Arabia
by: Danish Mahmood, et al.
Published: (2020-01-01)

Influence of generics in prescribing dynamics of proton pump inhibitors in general practice
by: Simona Cammarota, et al.
Published: (2009-03-01)

Indomethacin-induced gastric ulceration in rats: Protective roles of Spondias mombin and Ficus exasperata
by: Saheed Sabiu, et al.
Published: (2015-01-01)

Comparison of Acid-neutralizing capacity of antacids in Erbil City
by: Dina Aziz Boya, et al.
Published: (2021-08-01)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
by: Amanda Kuhl, et al.
Published: (2020-03-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Functional dyspepsia in adolescents: particulars of its etiology, premorbid background, and a comprehensive treatment approach
by: D. V. Pechkurov, et al.
Published: (2017-02-01)

Association between the chronic use of gastric acid suppressants and high‐risk colorectal polyps
by: Yasutoshi Shiratori, et al.
Published: (2021-03-01)

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
by: Simone Marconcini, et al.
Published: (2019-10-01)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
by: Yohannes T. Ghebre, et al.
Published: (2018-05-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
by: Conor P. Duffy, et al.
Published: (2020-07-01)

A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis
by: Euan R. O. Allan, et al.
Published: (2017-05-01)

Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity
by: Yanxia Guo, et al.
Published: (2016-12-01)

Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores
by: Yamamichi Nobutake, et al.
Published: (2012-05-01)

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
by: Jiangbi Li, et al.
Published: (2021-08-01)

Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study
by: Liang-Yu Chen, et al.
Published: (2020-11-01)

Angiogenesis as a pathologic mechanism and novel therapeutic target in an animal model of multiple sclerosis
by: MacMillan, Carolyn Jo-Anne
Published: (2013)

Functional dyspepsia. Different mechanisms, comprehensive treatment
by: A.E. Dorofeyev, et al.
Published: (2017-09-01)

Combination therapy versus monotherapy for gastroesophageal reflux in children with difficult-to-treat bronchial asthma
by: Adel Salah Bediwy, et al.
Published: (2014-01-01)

The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux—A Prospective Longitudinal Interventional Study
by: Christoph Castellani, et al.
Published: (2017-10-01)

Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Rosetta Pedotti, et al.
Published: (2012-11-01)

Pharmacokinetics of the Yougui pill in experimental autoimmune encephalomyelitis model rats and its pharmacological activity in vitro
by: Liu H, et al.
Published: (2019-07-01)

The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: A nationwide, population-based, cohort study
by: Shou-Wu Lee, et al.
Published: (2015-01-01)

Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis
by: Zahra Zamanzadeh, et al.
Published: (2016-10-01)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
by: Sofia P. das Neves, et al.
Published: (2018-10-01)

Anti-encephalitogenic effects of cucumber leaf extract
by: Bojan Jevtić, et al.
Published: (2017-10-01)

Allopregnanolone and Neuroinflammation: a Focus on Multiple Sclerosis
by: Farshid eNoorbakhsh, et al.
Published: (2014-06-01)

Prevalence of Gastroesophageal Reflux Disease (GERD) in Dyspepsia Patients in Primary Referral Hospital
by: Nikko Darnindro, et al.
Published: (2018-08-01)

Frequency of Clinical symptoms of Gastroesophageal Reflux Disease in Asthmatic Patients
by: Nadeem Hafeez, et al.
Published: (2019-01-01)

Integrative Treatment of Reflux and Functional Dyspepsia in Children
by: Ann Ming Yeh, et al.
Published: (2014-08-01)

Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis
by: Petra Hundehege, et al.
Published: (2018-11-01)

Functional Dyspepsia
by: Jung Hwan Oh, et al.
Published: (2019-02-01)

Practical Approaches to the Management of Patients with Dyspepsia
by: S.M. Tkach
Published: (2016-02-01)

Functional Dyspepsia and Chronic Gastritis: Similarities and Differences
by: S.M. Tkach
Published: (2014-09-01)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
by: Tobias Ruck, et al.
Published: (2015-07-01)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Dhaiban S, et al.
Published: (2020-09-01)

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis
by: Polak Paul E, et al.
Published: (2012-12-01)